This paper is in the following e-collection/theme issue:

Web-based and Mobile Health Interventions (4048) Innovations and Technology for Healthy Eating Education (490) Innovations and Technology for Physical Activity Education (936) Formative Evaluation of Digital Health Interventions (3268)

Published on in Vol 23, No 1 (2021): January

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/20491, first published .
Digital Intervention With Lifestyle Coach Support to Target Dietary and Physical Activity Behaviors of Adults With Nonalcoholic Fatty Liver Disease: Systematic Development Process of VITALISE Using Intervention Mapping

Digital Intervention With Lifestyle Coach Support to Target Dietary and Physical Activity Behaviors of Adults With Nonalcoholic Fatty Liver Disease: Systematic Development Process of VITALISE Using Intervention Mapping

Digital Intervention With Lifestyle Coach Support to Target Dietary and Physical Activity Behaviors of Adults With Nonalcoholic Fatty Liver Disease: Systematic Development Process of VITALISE Using Intervention Mapping

Authors of this article:

Kate Hallsworth1, 2, 3 Author Orcid Image ;   Stuart McPherson1, 2, 3 Author Orcid Image ;   Quentin M Anstee1, 2, 3 Author Orcid Image ;   Darren Flynn4 Author Orcid Image ;   Laura Haigh1, 2, 3 Author Orcid Image ;   Leah Avery3, 4 Author Orcid Image
Article Authors Cited by (25) Tweetations (14) Metrics

Journals

  1. Meloncelli N, Young A, Christoffersen A, Rushton A, Zhelnov P, Wilkinson S, Scott A, de Jersey S. Co‐designing nutrition interventions with consumers: A scoping review. Journal of Human Nutrition and Dietetics 2023;36(3):1045 View
  2. Guo B, Cheng Y, Yao L, Zhang J, Lu J, Qi H, Chen H. LncRNA HOTAIR regulates the lipid accumulation in non-alcoholic fatty liver disease via miR-130b-3p/ROCK1 axis. Cellular Signalling 2022;90:110190 View
  3. Nassir F. NAFLD: Mechanisms, Treatments, and Biomarkers. Biomolecules 2022;12(6):824 View
  4. Bachri ‪, Wismanadi H, Izzati U, Jannah M. Development of a Referral System to Optimize Centers for Character Development and Counseling Guidance as Well as Psychological Service Centers for Professional Learning and Development Institutions. IJORER : International Journal of Recent Educational Research 2023;4(1):91 View
  5. Essery R, Pollet S, Bradbury K, Western M, Grey E, Denison-Day J, Smith K, Hayter V, Kelly J, Somerville J, Stuart B, Becque T, Zhang J, Slodkowska-Barabasz J, Mowbray F, Ferrey A, Yao G, Zhu S, Kendrick T, Griffin S, Mutrie N, Robinson S, Brooker H, Griffiths G, Robinson L, Rossor M, Ballard C, Gallacher J, Rathod S, Gudgin B, Phillips R, Stokes T, Niven J, Little P, Yardley L. Parallel randomized controlled feasibility trials of the “Active Brains” digital intervention to protect cognitive health in adults aged 60–85. Frontiers in Public Health 2022;10 View
  6. Iruzubieta P, Bataller R, Arias-Loste M, Arrese M, Calleja J, Castro-Narro G, Cusi K, Dillon J, Martínez-Chantar M, Mateo M, Pérez A, Rinella M, Romero-Gómez M, Schattenberg J, Zelber-Sagi S, Crespo J, Lazarus J. Research Priorities for Precision Medicine in NAFLD. Clinics in Liver Disease 2023;27(2):535 View
  7. Lazarus J, Villota-Rivas M, Jiménez-González C, Santos-Laso A, Iruzubieta P, Arias-Loste M, Rice-Duek L, Leigh S, Kopka C, Turnes J, Calleja J, Crespo J. Physicians' Use of Digital Health Interventions in the Management of Nonalcoholic Fatty Liver Disease. Clinics in Liver Disease 2023;27(2):515 View
  8. Stine J, Long M, Corey K, Sallis R, Allen A, Armstrong M, Conroy D, Cuthbertson D, Duarte-Rojo A, Hallsworth K, Hickman I, Kappus M, Keating S, Pugh C, Rotman Y, Simon T, Vilar-Gomez E, Wong V, Schmitz K. American College of Sports Medicine (ACSM) International Multidisciplinary Roundtable report on physical activity and nonalcoholic fatty liver disease. Hepatology Communications 2023;7(4) View
  9. Avery L, Smith H, McPherson S, Hallsworth K. Feasibility and acceptability of an evidence-informed digital intervention to support self-management in people with non-alcoholic fatty liver disease: protocol for a non-randomised feasibility study (VITALISE). Pilot and Feasibility Studies 2023;9(1) View
  10. Zhou R, Gu Y, Zhang B, Kong T, Zhang W, Li J, Shi J. Digital Therapeutics: Emerging New Therapy for Nonalcoholic Fatty Liver Disease. Clinical and Translational Gastroenterology 2023;14(4):e00575 View
  11. STINE J, LONG M, COREY K, SALLIS R, ALLEN A, ARMSTRONG M, CONROY D, CUTHBERTSON D, DUARTE-ROJO A, HALLSWORTH K, HICKMAN I, KAPPUS M, KEATING S, PUGH C, ROTMAN Y, SIMON T, VILAR-GOMEZ E, WONG V, SCHMITZ K. Physical Activity and Nonalcoholic Fatty Liver Disease: A Roundtable Statement from the American College of Sports Medicine. Medicine & Science in Sports & Exercise 2023;55(9):1717 View
  12. Lazarus J, Mark H, Allen A, Arab J, Carrieri P, Noureddin M, Alazawi W, Alkhouri N, Alqahtani S, Arrese M, Bataller R, Berg T, Brennan P, Burra P, Castro-Narro G, Cortez-Pinto H, Cusi K, Dedes N, Duseja A, Francque S, Hagström H, Huang T, Wajcman D, Kautz A, Kopka C, Krag A, Miller V, Newsome P, Rinella M, Romero D, Sarin S, Silva M, Spearman C, Tsochatzis E, Valenti L, Villota-Rivas M, Zelber-Sagi S, Schattenberg J, Wong V, Younossi Z, Lazarus J, Huang T, Aberg F, Adams L, Al-Naamani K, Albadawy R, Alexa Z, Allison M, Alnaser F, Alswat K, Alvares-da-Silva M, Alvaro D, Alves-Bezerra M, Andrade R, Anstee Q, Awuku Y, Baatarkhuu O, Baffy G, Bakieva S, Bansal M, Barouki R, Batterham R, Behling C, Belfort-DeAguiar R, Berzigotti A, Betel M, Bianco C, Bosi E, Boursier J, Brunt E, Bugianesi E, Byrne C, Cabrera Cabrejos M, Caldwell S, Carr R, Castellanos Fernández M, Castera L, Castillo-López M, Caussy C, Cerda-Reyes E, Ceriello A, Chan W, Chang Y, Charatcharoenwitthaya P, Chavez-Tapia N, Chung R, Colombo M, Coppell K, Cotrim H, Craxi A, Crespo J, Dassanayake A, Davidson N, De Knegt R, de Ledinghen V, Demir M, Desalegn H, Diago M, Dillon J, Dimmig B, Dirac M, Dirchwolf M, Dufour J, Dvorak K, Ekstedt M, El-Kassas M, Elsanousi O, Elsharkawy A, Elwakil R, Eskridge W, Eslam M, Esmat G, Fan J, Ferraz M, Flisiak R, Fortin D, Fouad Y, Freidman S, Fuchs M, Gadano A, Gastaldelli A, Geerts A, Geier A, George J, Gerber L, Ghazinyan H, Gheorghe L, Kile D, Girala M, Boon Bee G, Goossens N, Graupera I, Grønbæk H, Hamid S, Hebditch V, Henry Z, Hickman I, Hobbs L, Hocking S, Hofmann W, Idilman R, Iruzubieta P, Isaacs S, Isakov V, Ismail M, Jamal M, Jarvis H, Jepsen P, Jornayvaz F, Sudhamshu K, Kakizaki S, Karpen S, Kawaguchi T, Keating S, Khader Y, Kim S, Kim W, Kleiner D, Koek G, Joseph Komas N, Kondili L, Koot B, Korenjak M, Kotsiliti E, Koulla Y, Kugelmas C, Kugelmas M, Labidi A, Lange N, Lavine J, Lazo M, Leite N, Lin H, Lkhagvaa U, Long M, Lopez-Jaramillo P, Lozano A, Macedo M, Malekzadeh R, Marchesini G, Marciano S, Martinez K, Martínez Vázquez S, Mateva L, Mato J, Nlombi C, McCary A, McIntyre J, McKee M, Mendive J, Mikolasevic I, Miller P, Milovanovic T, Milton T, Moreno-Alcantar R, Morgan T, Motala A, Muris J, Musso C, Nava-González E, Negro F, Nersesov A, Neuschwander-Tetri B, Nikolova D, Norris S, Novak K, Ocama P, Ong J, Ong-Go A, Onyekwere C, Padilla M, Pais R, Pan C, Panduro A, Panigrahi M, Papatheodoridis G, Paruk I, Patel K, Gonçalves C, Figueroa M, Pérez-Escobar J, Pericàs J, Perseghin G, Pessoa M, Petta S, Marques Souza de Oliveira C, Prabhakaran D, Pyrsopoulous N, Rabiee A, Ramji A, Ratziu V, Ravendhran N, Ray K, Roden M, Romeo S, Romero-Gómez M, Rotman Y, Rouabhia S, Rowe I, Sadirova S, Alkhatry M, Salupere R, Satapathy S, Schwimmer J, Sebastiani G, Seim L, Seki Y, Serme A, Shapiro D, Sharvadze L, Shaw J, Shawa I, Shenoy T, Shibolet O, Shimakawa Y, Shubrook J, Singh S, Sinkala E, Skladany L, Skrypnyk I, Song M, Sookoian S, Sridharan K, Stefan N, Stine J, Stratakis N, Sheriff D, Sundaram S, Svegliati-Baroni G, Swain M, Tacke F, Taheri S, Tan S, Tapper E, Targher G, Tcaciuc E, Thiele M, Tiniakos D, Tolmane I, Torre A, Torres E, Treeprasertsuk S, Trenell M, Turcan S, Turcanu A, Valantinas J, van Kleef L, Velarde Ruiz Velasco J, Vesterhus M, Vilar-Gomez E, Waked I, Wattacheril J, Wedemeyer H, Wilkins F, Willemse J, Wong R, Yilmaz Y, Yki-Järvinen H, Yu M, Yumuk V, Zeybel M, Zheng K, Zheng M. A global research priority agenda to advance public health responses to fatty liver disease. Journal of Hepatology 2023;79(3):618 View
  13. Ang S, Lim S, Dan Y, Chan Y, Yap Q, Chen J. Clinical Service Incorporating Mobile Technology on Weight Loss in Patients With Metabolic Dysfunction–Associated Steatotic Liver Disease: A Translation From Research Trial. Endocrinology, Diabetes & Metabolism 2024;7(3) View
  14. Loughran K, Emerson J, Avery L, Suri S, Flynn D, Kaner E, Rapley T, Martin D, McPhee J, Fernandes-James C, Harrison S. Exercise-based interventions targeting balance and falls in people with COPD: a systematic review and meta-analysis. European Respiratory Review 2024;33(172):240003 View
  15. Lee J, Yoon E, Oh J, Kim K, Ahn S, Jun D. Barriers to care linkage and educational impact on unnecessary MASLD referrals. Frontiers in Medicine 2024;11 View
  16. Deng Q, Lv R, Zou H, Zou T. Beneficial effects of intermittent fasting on nonalcoholic fatty liver disease: a narrative review. Egyptian Liver Journal 2024;14(1) View
  17. Wang J, Wang Z, Yu Y, Cheng S, Wu J. Advances in research on metabolic dysfunction-associated steatotic liver disease. Life Sciences 2025;362:123362 View
  18. Radmehr M, Homayounfar R, Djazayery A. The relationship between anthropometric indices and non-alcoholic fatty liver disease in adults: a cross-sectional study. Frontiers in Nutrition 2025;11 View
  19. Avery L, Smith H, Livingston R, McPherson S, Innerd A, Hallsworth K. Feasibility of a digital lifestyle intervention (VITALISE) to support weight loss in patients with MASLD in routine secondary care. BMJ Open Gastroenterology 2025;12(1):e001771 View
  20. Wal P, Yadav S, Jha S, Singh A, Bhargavi B, Shivaram R, Imran M, Aziz N. Role of natural compounds in non-alcoholic fatty liver diseases (NAFLD): a mechanistic approach. Egyptian Liver Journal 2025;15(1) View
  21. Herbert T, Malone M, Rhind N, Cooper K. Intervention mapping in the development of health promotion interventions for adults with chronic conditions: a scoping review. JBI Evidence Synthesis 2025;23(11):2236 View
  22. hasannia F, Keshavarz A, Shadnoush M. Investigating the Effect of Royal Jelly Supplementation on Improvement of Glucose Profile, Lipid Profile, Liver Factors, Inflammation and Anthropometric Indices in Patients with Non-alcoholic Fatty Liver Disease in the Nutrition Clinic of the Islamic Azad University and Shahid Beheshti Medical Sciences Hospital Centers in 1402, a Randomized, Double-Blind Clinical Trial. Journal of Nutrition Sciences and Food Technology 2025;20(3):21 View
  23. Evon D, Liu C, Rollason C, Lechner S, Brown A, Harrison D, Stewart P, Bailey D, Morland L, Barritt A. Group-based telehealth stress management—lifestyle interventions are feasible for patients with chronic liver disease. Hepatology Communications 2025;9(12) View
  24. 黎 春. Non-Alcoholic Fatty Liver Disease (NAFLD): A Review of Risk Factors, Pathogenesis, and Treatment. Advances in Clinical Medicine 2025;15(11):2436 View
  25. Alfawaz M, Elmorsy E, Alshammari A, Hakim N, Jawad N, Hassan S, Fawzy M, Esmaeel S. Carvacrol-Loaded Chitosan Nanoparticles as a Multifunctional Nanotherapeutic Strategy Targeting Oxidative Stress, Inflammation, Apoptosis, and Genotoxicity in Nonalcoholic Fatty Liver Disease. Antioxidants 2025;14(12):1432 View